XIGDUO 5 mg/1000 mg, comprimé pelliculé — plaquette(s) PVC (ACLAR RX) polytrifluorochloroéthylène aluminium de 60 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400927886768
  • CIP7 2788676
  • CIS 60267506
  • Registration number EU/1/13/900

What the source publishes

Holder
ASTRAZENECA AB
Active ingredients
CHLORHYDRATE DE METFORMINE, DAPAGLIFLOZINE PROPANEDIOL MONOHYDRATÉ, DAPAGLIFLOZINE
Form
comprimé pelliculé
Package
plaquette(s) PVC (ACLAR RX) polytrifluorochloroéthylène aluminium de 60 comprimé(s)
Routes
orale
Administrative status
authorised
Supply regime
liste I
Marketing status
Déclaration de commercialisation
Authorised on
2014-01-16
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400927886768
{
  "cis": "60267506",
  "cip7": "2788676",
  "form": "comprimé pelliculé",
  "name": "XIGDUO 5 mg/1000 mg, comprimé pelliculé — plaquette(s) PVC (ACLAR RX) polytrifluorochloroéthylène aluminium de 60 comprimé(s)",
  "cip13": "3400927886768",
  "holder": "ASTRAZENECA AB",
  "routes": [
    "orale"
  ],
  "holders": [
    "ASTRAZENECA AB"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "37.59",
  "authorisedOn": "2014-01-16",
  "compositions": [
    {
      "name": "CHLORHYDRATE DE METFORMINE",
      "nature": "SA",
      "strength": "1000 mg",
      "linkageNumber": "2",
      "substanceCode": "24321",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "DAPAGLIFLOZINE PROPANEDIOL MONOHYDRATÉ",
      "nature": "SA",
      "strength": "6,15 mg",
      "linkageNumber": "1",
      "substanceCode": "41338",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "DAPAGLIFLOZINE",
      "nature": "FT",
      "strength": "5 mg",
      "linkageNumber": "1",
      "substanceCode": "50433",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "36.57",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "XIGDUO 5 mg/1000 mg, comprimé pelliculé",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "plaquette(s) PVC (ACLAR RX) polytrifluorochloroéthylène aluminium de 60 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65 %"
  ],
  "marketingDeclaredOn": "2020-04-06",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "CHLORHYDRATE DE METFORMINE",
    "DAPAGLIFLOZINE PROPANEDIOL MONOHYDRATÉ",
    "DAPAGLIFLOZINE"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": "Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Diabète dit \"de type 2\"  : si un traitement de ce diabète n'a pas donné satisfaction en utilisant de la metformine seule, ou de la metformine associée à un sulfamide hypoglycémiant, ou de la metformine associée à de l'insuline    ou encore pour remplacer un traitement qui associait séparément les deux principes actifs qui constituent ce médicament. ; JOURNAL OFFICIEL ; 01/04/20",
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/13/900",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400927886768"